The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells

Pharmazie

Volumn 64, Issue 3, 2009, Pages 214-216

  Imai, S ^a,b   Yoshida, Y ^a,b   Okamura, T ^a,b   Nagano, K ^a,b   Abe, Y ^a   Yoshikawa, T ^a,b   Kamada, H ^a,b   Nakagawa, S ^b   Tsunoda, Shin Ichi ^a,b   Tsutsumi, Y ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; 2-METHOXYESTRADIOL; DRUG DERIVATIVE; ESTRADIOL; MESSENGER RNA;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; ANGIOGENESIS; BIOSYNTHESIS; BLOOD VESSEL; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

BLOOD VESSELS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; ESTRADIOL; HUMANS; LYMPHANGIOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 65349154481     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8776     Document Type: Article

References (17)

1. Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438: 946-953.
2. Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D'Amato RJ (2008) 2-Methoxyestradiol inhibits hypoxia-inducible factor-1 {alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 172: 534-544.
3. Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A, Holden NS, Bergmann MW, Barnes PJ, Newton R (2004) Inhibition of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. J Biol Chem 279: 18457-18466
4. Daiani M, Kalchenko V, Yosepovich A, Margalit R, Hassid Y, Degani H, Seger D (2006) Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res 66 : 8037-8041.
5. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J National Cancer Inst 94: 819-825.
6. Harrell MI, Iritani BM, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170: 774-786.
7. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65: 4739-4746.
8. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promoted tumor metastasis to distant sites. Blood 109: 1010-1017.
9. Hoshida T, Isaka N, Hagendoorn J, Tomaso ED, Chen Y, Pytowski B, Fukumura D, Padera TP, Jain RK (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66: 8065-8075.
10. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, Laakkonen P, Petrova T, Langer B, Raab I (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15: 603-612.
11. Mooberry SL (2003) Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6: 355-361.
12. Nofer JR, Junker R, Seedorf U, Assmann G, Zidek W and Tepel M (2000) D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes. Cell Signal 12: 289-296.
13. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886.
14. Saban MR, Mémet S, Jackson DG, Ash J, Roig AA, Israël A, Saban R (2004) Visualization of lymphatic vessels through NF-kappa B activity. Blood 104: 3228-3230.
15. Shimizu K, Kubo H, Yamaguchi K, Kawashima K, Ueda Y, Matsuo K, Awane M, Shimahara Y, Takabayashi A, Yamaoka Y, Satoh S (2004) Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95: 328-333.
16. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K (2002) Lymphangiogenesis and cancer metastasis. Nature Rev Cancer 2: 573-583.
17. Zhou D, Matchett GA, Jadhav V, Dach N, Zhang JH (2008) The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats. Neurol Res 30: 268-271.